| Literature DB >> 33423183 |
Ayako Iwasaki1, Chikao Nakayama2, Koichi Fujiwara3,4, Yukiyoshi Sumi5, Masahiro Matsuo5, Manabu Kano2, Hiroshi Kadotani6.
Abstract
PURPOSE: Sleep apnea syndrome (SAS) is a prevalent sleep disorder in which apnea and hypopnea occur frequently during sleep and result in increase of the risk of lifestyle-related disease development as well as daytime sleepiness. Although SAS is a common sleep disorder, most patients remain undiagnosed because the gold standard test polysomnography (PSG), is high-cost and unavailable in many hospitals. Thus, an SAS screening system that can be used easily at home is needed.Entities:
Keywords: Machine learning; Sleep apnea syndrome; Telemedicine; Wearable sensor
Mesh:
Year: 2021 PMID: 33423183 PMCID: PMC8590683 DOI: 10.1007/s11325-020-02249-0
Source DB: PubMed Journal: Sleep Breath ISSN: 1520-9512 Impact factor: 2.816
Fig. 1a Feature extraction framework. b LSTM architecture. sigmoid: sigmoid function , ⊕: calculate the sum of two matrices, ⊗: calulate the hadamard product of two matrices
Subject profile
| Male | Female | |||||
|---|---|---|---|---|---|---|
| Age | AHI 0–14 | 15–29 | 30– | 0–14 | 15–29 | 30– |
| 18–30 | 7 | 0 | 0 | 15 | 0 | 1 |
| 31–50 | 7 | 2 | 5 | 6 | 0 | 0 |
| 51–80 | 0 | 7 | 7 | 0 | 1 | 1 |
Fig. 2a, b Example of RRI: patient P1 (top) and healthy person H2 (bottom)
Fig. 3a, b AS ratios when using raw RRI: modeling data (left) and validation data (right)
Screening accuracy of existing devices and the proposed algorithm
| Product | Sensitivity (%) | Specificity (%) |
|---|---|---|
| Healthdyne 202-11 Oximeter | 97 | 80 |
| Nellcor N-200 | 82 | 76 |
| SageTech SNORESAT | 100 | 63 |
| ResMed AutoSet 3.03 | 97 | 32 |
| Criticare 504 5 0ximeter | 67 | 92 |
| Konica Minolta Pulsox 7 | 94 | 62 |
| Proposed | 100 | 100 |
Fig. 4a Example of screening result for each subject: a patient (left) and a healthy subject (right). b CVPR of patient P1 (top: normal respiration period, bottom: apnea period)
Fig. 5Arrhythmic events and classification results: arrhythmia period (green) and estimated respiratory conditions (blue)
Fig. 6a, b AS ratios when using HRV features: modeling data (left) and validation data (right)